TiE Inflect 2018 announces CONCENTER BIOPHARMA as a 2018 TiE50 Finalist.

The 6th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel, February

We have been chosen as 1 out of 5 Israeli companies that will continue to the Semi-Final Competition in China - December.

Come meet us and hear our presentation at the 3rd World Congress on Clinical Trials in Diabetes (WCTD2018), which will take place 3-4 Decem

Come meet us and hear our presentation at the 2nd World Congress on Clinical Trials in Diabetes (WCTD2017), which will take place 27-28...